Editas Medicine (EDIT) Assets Average (2016 - 2025)

Editas Medicine (EDIT) has reported Assets Average for 10 consecutive years, with $194.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Assets Average fell 41.97% year-over-year to $194.1 million; the TTM figure through Dec 2025 stood at $194.1 million (down 41.97% YoY), while the FY2025 annual figure was $264.1 million, down 37.18% from the prior year.
• Assets Average fell to $194.1 million in Q4 2025 per EDIT's latest filing, from $206.2 million in the prior quarter.
• Across five years, Assets Average topped out at $768.1 million in Q2 2021 and bottomed at $194.1 million in Q4 2025.
• Historically, Assets Average has averaged $487.0 million across 5 years, with a median of $502.5 million in 2023.
• Annual changes were most pronounced in 2021 — Assets Average jumped 38.67% — and 2025, when it plunged 42.53%.
• Editas Medicine's Assets Average stood at $697.3 million in 2021, then fell by 25.04% to $522.7 million in 2022, then declined by 3.97% to $501.9 million in 2023, then slumped by 33.34% to $334.6 million in 2024, then tumbled by 41.97% to $194.1 million in 2025.
• Business Quant data shows EDIT's Assets Average at $194.1 million in Q4 2025, $206.2 million in Q3 2025, and $237.1 million in Q2 2025.